Location: London, England
Start Date: November 7, 2019
End Date: November 8, 2019
Join Oxford Global for the 5th Annual Genome Editing Congress on the 7 – 8th November 2019 in London, UK to gain valuable insights into how this potential can be realised. The congress will showcase the latest technologies and therapeutic solutions that are being produced by pioneers in the genome editing field.
On Day 1, we explore the most recent optimization of genome editing technologies, including key presentations from Barry Rosen, Vice President and Senior Scientist, AstraZeneca and Bill Skarnes, Professor and Director, The Jackson Laboratory for Genomic Medicine.
Following our morning workshop on genetic assay and screening developments in a therapeutic context, Day 2 of the congress will feature a highly anticipated talk about the Sangamo Zinc Finger gene editing programme from David Fenard, Director of Cell Engineering, Sangamo Therapeutics, in addition to a case study from Cellectis regarding their TALEN-mediated clinical trials.
View the agenda: https://bit.ly/2lYYTp3
For more information about the programme and registration, please contact Bradley Copeman at firstname.lastname@example.org or visit the website: https://bit.ly/2lZQn9l
Go Social: Join our Genomics Networking Group on LinkedIn, follow us on Twitter @xgenseq & join the conversation at #GENSERIESUK19